Radisens has a business to business commercial approach with the aim to develop strategic partnerships including technology licensing, development, manufacture and supply with collaborators in decentralised chronic disease monitoring and related markets. In addition, the Gemini™ platform is expandable for the measurement of analytes other than those developed to date by Radisens.

Talk to us now

We welcome approaches from organisations that seek to develop and enhance their competitive edge, or expand into decentralised chronic disease monitoring or related markets where a fully quantitative, rapid diagnostic tool with instant off-the-shelf use is needed.

For controlled access to our data room, please sign-in below:

Forgot your password?